• 제목/요약/키워드: Reproductive hormone

검색결과 541건 처리시간 0.023초

Understanding the molecular mechanisms of bisphenol A action in spermatozoa

  • Rahman, Md Saidur;Pang, Myung-Geol
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제46권3호
    • /
    • pp.99-106
    • /
    • 2019
  • Bisphenol A (BPA) is an endocrine-disrupting chemical that is capable of interfering with the normal function of the endocrine system in the body. Exposure to this chemical from BPA-containing materials and the environment is associated with deleterious health effects, including male reproductive abnormalities. A search of the literature demonstrated that BPA, as a toxicant, directly affects the cellular oxidative stress response machinery. Because of its hormone-like properties, it can also bind with specific receptors in target cells. Therefore, the tissue-specific effects of BPA mostly depend on its endocrine-disrupting capabilities and the expression of those particular receptors in target cells. Although studies have shown the possible mechanisms of BPA action in various cell types, a clear consensus has yet to be established. In this review, we summarize the mechanisms of BPA action in spermatozoa by compiling existing information in the literature.

Dienogest in endometriosis treatment: A narrative literature review

  • Joowon Lee;Hyeon Ji Park;Kyong Wook Yi
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제50권4호
    • /
    • pp.223-229
    • /
    • 2023
  • Endometriosis is characterized by the implantation of endometrial cells outside the uterus. This hormone-dependent disease is highly prevalent among women of reproductive age. Clinical symptoms of endometriosis include dysmenorrhea, pelvic pain, and infertility, which can negatively impact the overall quality of life of those affected. The medical treatment of endometriosis serves as an important therapeutic option, aimed at alleviating pain associated with the condition and suppressing the growth of endometriotic lesions. As such, it is employed as an adjuvant therapy following surgery or an empirical treatment after the clinical diagnosis of endometriosis. Dienogest, a fourth-generation progestin, has received approval for the treatment of endometriosis in many countries. A growing body of evidence has demonstrated its efficacy in managing endometriosis-associated pain, preventing symptoms, and reducing lesion recurrence. In this review, we examine the clinical efficacy, safety, and tolerability of dienogest in treating endometriosis. We also provide updated findings, drawing from clinical studies that focus on the long-term use of this medication in patients with endometriosis.

GH Increases the Progesterone at Peri-estrus Stage in Mice Co-injected with PMSG for Superovulation

  • Kim, Young-Gee;Ryoo, Zae-Young;Park, Young-Sik
    • Reproductive and Developmental Biology
    • /
    • 제35권4호
    • /
    • pp.519-525
    • /
    • 2011
  • Growth hormone (GH) is obligatory for growth and development. But, there is controversy on the GH effect about reproductive processes of sexual differentiation, pubertal maturation, gonadal steroidogenesis, gametogenesis and ovulation. This study was conducted to investigate the effect of GH on estrus, ovulation and embryo implantation. The results obtained were as follows. GH stimulated to increase estrus rate (p<0.05), pregnancy rate (p<0.05), and total fetus number in mice treated for superovulation. Also, the correlation between GH and steroids, E2 and P4, at peri-estrus stage/ peri-ovulation stage/ peri-implantation stage of the superovulation-induced mice was examined. Consequently, GH co-injected with PMSG especially increased P4 level (p<0.05) at peri-estrus stage of superovulationinduced mice. In conclusion, GH co-treatment in superovulation system boosted the rate of estrus, pregnancy and total fetus by increasing progesterone level at peri-estrus stage of superovulation-induced mice.

인간의 자궁에서의 Luteinizing Hormone (LH) 유전자 발현 (Expression of Luteinizing Hormone(LH) Gene in Human Uterus)

  • 김성례;이성호
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제26권3호
    • /
    • pp.377-381
    • /
    • 1999
  • Objectives: Recent studies, including our own, demonstrated that the novel expression of LH gene in rat gonads and uterus, indicating that the local production and action of the LH-like molecule. In the present study, we investigated whether human uterus also expresses the LH gene. Design: Reverse transcription-polymerase chain reaction (RT-PCR) amplified the cDNA fragments coding $LH_{\beta}$ polypeptide from human endometrium but not from myometrium. Presence of the transcripts for the ${\alpha}$-subunit in human endometrium was also confirmed by RT-PCR. Results: Transcripts for $LH_{\beta}$ subunit were detected in endometrial samples from women with endometriosis. The gene for LH/hCG receptor was expressed in both endometrium and myometrium, showing good agreement with previous studies. Increased level of $LH_{\beta}$ transcript was determined in the endometrium from follicular phase compared to that from luteal phase. Conclusion: Taken together, our findings demonstrated that 1) the genes for LH subunits and LH/hCG receptor are expressed in human uterus, 2) the uterine LH expression was changed during menstrual cycle, suggesting that the uterine LH may playa local role in the control of uterine physiology and function(s).

  • PDF

Protective Effects of Blue Honeysuckle on Rat Hypothyroidism Induced by Propylthiouracil

  • Lee, Woo-Yeol;Yi, Seong-Joon;Yun, Sungho;Lim, Mee-Kyung;Lee, Keun-Woo
    • 한국임상수의학회지
    • /
    • 제33권5호
    • /
    • pp.246-254
    • /
    • 2016
  • The objective of the present study is to determine whether blue honeysuckle lyophilized concentrated powder (BH) has favorable effects on hypothyroidism and related reproductive organ damage. Hypothyroidism was induced by 9 subcutaneous administration of propylthiouracil (PTU) for 28 days. Levothyroxine (LT4)-treated group was intraperitoneally injected with LT4 for the same period, while for BH (125, 250, and 500 mg/kg) or Flos Lonicerae lyophilized aqueous extract (LF, 250 mg/kg)-treated groups, the test materials were orally administrated for 42 days: two weeks before PTU injection and during PTU administration. The changes in serum thyroid hormone levels, serum male sex hormone levels, and testis antioxidant defense system were observed by histopathology of the thyroid gland, epididymis, prostate, and testis. The oral administrations of 125, 250, and 500 mg/kg of BH showed favorable effects compared to LF on hypothyroidism and related damages of reproductive organs through augmentation of the antioxidant defense system in the testis. In conclusion, BH is a promising new potent thyroid gland protecting agent.

Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review

  • Jee, Byung Chul
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제49권2호
    • /
    • pp.76-86
    • /
    • 2022
  • Ovarian cystectomy is the preferred technique for the surgical management of ovarian endometrioma. However, other techniques such as ablation or sclerotherapy are also commonly used. The aim of this review is to summarize information regarding the efficacy of ablation and sclerotherapy compared to cystectomy in terms of ovarian reserve, the recurrence rate, and the pregnancy rate. Several studies comparing ablation versus cystectomy or sclerotherapy versus cystectomy in terms of the serum anti-Müllerian hormone (AMH) decrement, endometrioma recurrence, or the pregnancy rate were identified and summarized. Both ablation and cystectomy have a negative impact on ovarian reserve, but ablation results in a smaller serum AMH decrement than cystectomy. Nonetheless, the recurrence rate is higher after ablation than after cystectomy. More studies are needed to demonstrate whether the pregnancy rate is different according to whether patients undergo ablation or cystectomy. The evidence remains inconclusive regarding whether sclerotherapy is better than cystectomy in terms of ovarian reserve. The recurrence rates appear to be similar between sclerotherapy and cystectomy. There is not yet concrete evidence that sclerotherapy helps to improve the pregnancy rate via in vitro fertilization in comparison to cystectomy or no sclerotherapy.

재래산양(在來山羊)의 성성숙(性成熟), 발정주기(發情週期) 및 임신기간(姙娠期間)에 따른 성(性) Hormone 수준(水準)의 변화(變化)에 관(關)한 연구(硏究)(I) -번식형질(繁殖形質)과 체성장(體成長)에 따른 혈청(血淸) 성(性) Hormone 수준(水準)의 변화(變化)- (Studies on the Sex Hormone Levels in Korean Native Goat during Puberty, Estrous Cycle and Pregnancy(I) - Studies on Reproductive Traits, and Changes of Sex Hormone Levels by Growth-)

  • 이규승;박창식;김영묵
    • 농업과학연구
    • /
    • 제12권1호
    • /
    • pp.55-61
    • /
    • 1985
  • 한국재래산양(韓國在來山羊)의 번식형질(繁殖形質)을 조사(調査)하고, 아울러 70일령(日令)부터 190일령(日令)까지 매(每)15일(日) 간격(間隔)으로 혈청(血淸) 성(性) hormone의 농도변화(濃度變化)를 조사(調査)하였다. 한국재래산양(韓國在來山羊)의 성성숙일령(性成熟日令)과 체중(體重)은 183.6일(日)과 14.3 kg이었고. 발정시기(發情時期)와 발정지속기간(發情持續期間)은 20.3일(日)과 36.7시간(時間)이었으며, 임신기간(姙娠期間), 복당산자수(腹當産仔數) 및 생시체중(生時體重)은 각각(各各) 148.4일(日), 1.4두(頭) 및 1.8 kg이었다. 혈청(血淸) LH의 수준(水準)은 70일령(日令)에서 3.93mIU/ml로 최고치(最高値)였고, 일령(日令)이 증가(增加)할수록 감소(減少)되는 경향(傾向) 이어서 190일령(日令)에는 1.21mIU/ml로 최소치(最少値)였다. FSH는 모든 관찰시간(觀察時間)에서 1.25 mIU/ml 以下의 수준(水準)이었다. Prolactin은 85일령(日令)에 3.09 ng/ml로 최소치(最少値)였고, 175일령(日令)에 4.65 ng/ml로 최고치(最高値)를 나타냈다. Estradiol-$17{\beta}$의 수준(水準)은 일령(日令)이 증가(增加)할수록 증가(增加)되는 경향(傾向)이어서 190일령(日令)에서 7.95 pg/ml로 최고치(最高値)를 나타냈다. Progesterone은 모든 관찰시간(觀察時間)에서 1.0 ng/ml 이하(以下)로서 매우 낮은 수준(水準)을 유지(維持)하였다.

  • PDF

과배란유도 여성에서 우성난포의 성장속도 (Growth Rate of Dominant Follicles During Controlled Ovarian Hyperstimulation)

  • 황은주;구승엽;김용진;지병철;서창석;김석현;최영민;김정구;문신용
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제37권3호
    • /
    • pp.253-259
    • /
    • 2010
  • 목 적: 과배란유도 환자에서의 우성난포의 성장속도와 임상인자들과의 연관성을 평가하고자 하였다. 연구방법: 체외수정시술을 위한 과배란유도 313주기를 대상으로 혈중 호르몬 농도를 측정하고 과배란유도 주기 중 난포 직경의 변화를 초음파를 이용하여 연속적으로 측정하였다. 우성난포의 성장 속도를 계산하고, 임상지표와의 연관성을 분석하였다. 결 과: Gonadotropin releasing hormone 작용제와 길항제 주기 사이에 우성난포의 성장속도의 유의한 차이는 관찰되지 아니하였다. 우성난포의 성장속도와 환자의 연령, 체질량 지수, 생리 시작 3일의 follicle stimulating hormone, luteinizing hormone, 에스트라디올, 획득 난자의 수, 수정률 등의 임상지표는 유의한 연관성이 없었다. 결 론: 본 연구 결과는 우성난포의 성장속도는 난소 반응을 포함한 임상지표와 연관성이 없는 독립적인 변수임을 시사한다.

Expression of Recombinant Human Follicle-stimulating Hormone in the Chinese Hamster Ovary Cell

  • Park, Ji-Hyun;Kim, Nam-Hyung;Hosup Shim;Kim, Teoan
    • 한국수정란이식학회:학술대회논문집
    • /
    • 한국수정란이식학회 2002년도 국제심포지엄
    • /
    • pp.100-100
    • /
    • 2002
  • As an preliminary experiment for making transgenic animals producing human follicle stimulating hormone (hFSH), we tried to express recombinant hFSH gene in vitro. hFSH is a heterodimeric glycoprotein hormone produced in the anterior pituitary gland. The hormone is essential in the regulation of reproductive processes, such as follicular development and ovulation. Genes encoding the common gonadotrophin alpha subunit and FSH-specific beta subunit were inserted into retroviral vectors under the control of the rat beta actin promoter. Gene transfer to the Chinese hamster ovary (CHO) cells was done by infection of the retroviruses harvested from PT67 packaging cells transfected with recombinant retrovirus vector DNA. After selection with G4l8, PCR and RT-PCR analyses of the G4l8-resistant CHO cells showed successful transfer and expression of both ${\alpha}$ and ${\beta}$ fragments of the FSH gene.

  • PDF